Phage therapy awarded the Leenaards Foundation Prize for translational research

Alex Persat (EPFL), Angela Koutsokera (CHUV) and Grégory Resch (CHUV). Photo: Alban Kakulya

Our warmest congratulations to NCCR PI Grégory Resch for winning the 2024 Prize for translational biomedical research from the Leenaards Foundation, together with collaborators Angela Koutsokera (CHUV) and Alex Persat (EPFL), for the development of phage therapy to fight bacterial infections resistant to antibiotics!

This Prize will be awarded on 21 March in the AGORA building in Lausanne during the Leenaards Sciences & Health Meeting.

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.